Supplementary Table 1.
Baseline characteristics of patients in PRBC transfusion group and no blood transfusion group in a propensity score model.
| Variable | PRBC group (n=204) | No transfusion group (n=204) | p Value |
|---|---|---|---|
| Male gender | 158 (77.5%) | 160 (78.4%) | 0.811 |
| Age (year) | 52±12 | 53±12 | 0.856 |
| Body mass index (kg/m2) | 22.6±3.4 | 23.0±3.0 | 0.263 |
| Cigarette smoking | 82 (40.2%) | 82 (40.2%) | 1.000 |
| Diabetes mellitus | 18 (8.8%) | 19 (9.3%) | 1.000 |
| HBV/HCV positive | 147 (72.1%) | 153 (75%) | 0.575 |
| Cardiovascular disease | 27 (13.2%) | 32 (15.7%) | 0.574 |
| Child-Pugh class | 0.724 | ||
| A | 199 (97.5%) | 201 (98.5%) | |
| B | 5 (2.5%) | 3 (1.5%) | |
| ASA classification | 0.141 | ||
| 1 | 6 (2.9%) | 7 (3.4%) | |
| 2 | 149 (73%) | 164 (80.4%) | |
| 3 | 49 (24%) | 33 (16.2%) | |
| ICG 15min retention (%) | 9.7±9.9 | 9.9±14.8 | 0.938 |
| Hepatic inflow occlusion | 142 (69.6%) | 141 (69.1%) | 1.000 |
| Tumor location | 0.108 | ||
| Left lobe | 57 (27.9%) | 44 (21.6%) | |
| Right lobe | 137 (67.2%) | 155 (76%) | |
| Bilobar involvement | 10 (4.9%) | 5 (2.5%) | |
| Primary disease | 0.762 | ||
| Hepatocellular carcinoma | 175 (85.8%) | 178 (87.3%) | |
| Intrahepatic cholangiocarcinoma | 19 (9.3%) | 15 (7.4%) | |
| Other liver malignancies | 10 (4.9%) | 11 (5.4%) | |
| Surgical procedures | 0.892 | ||
| Minor hepatectomy | 173 (84.8%) | 171 (83.8%) | |
| Major hepatectomy | 31 (15.2%) | 33 (16.2%) |
PRBC – packed red blood cells; HBV – hepatitis B virus; HCV – hepatitis C virus; ASA – the American Society of Anesthesiologists; ICG – indocyanine green.